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Herrmann and Niedobitek have recently ruled out the
involvement of Epstein–Barr virus (EBV) in the pathogene-
sis of breast carcinomas [1]. They looked for EBNA-1
(EBV nuclear antigen 1) and EBER (EBV-encoded small
RNA) in 59 breast carcinoma biopsies. They stated that
because the available antibodies to detect EBNA-1
usually produce only weak staining, a lack of EBNA-1
expression could not be taken as proof that the virus was
absent and, besides, that this antibody could also cross-
react with other proteins. Interestingly, they failed to find
either specific or nonspecific staining among the 59 cases
studied, and concluded that EBV was absent [1].
However, we observed nuclear granular EBNA-1 staining
in tumor epithelial cells in paraffin-embedded sections
from 14/33 American women with breast carcinoma [2]
and 24/69 Argentine ones (data not published), while
normal cells (including lymphocytes) were negative for
EBNA-1 in all the analyzed cases. Thus, in our own experi-
ence and that reported by other authors, the anti-EBNA-1
2B-4 monoclonal antibody reacted specifically in EBV+
tumor epithelial cells [3].
Herrmann and  Niedobitek also detected EBV DNA by
PCR in paraffin-embedded breast carcinoma biopsies, but
they assumed that it was probably related to the presence
of EBV-infected lymphocytes in tumor stroma [1]. However,
authors of previous studies have reported 21% [4], 51%
[3], and 32% [5] of EBV+ breast cancers with various
grades of infiltrating lymphocytes identified by BamHIW
PCR. We confirmed our positive EBNA-1 results by PCR
in 24/69 patients from whom DNA of good quality was
also available, detecting amplification fragments of 122 bp
from the BamHIW region and 108 bp from the EBER
region. No amplification product for EBV was detected, by
either  BamHIW PCR or EBER PCR, in 30 biopsies of
benign breast tumors with no atypia, 8 normal breast
tissues, and 45 EBNA-1– breast carcinomas with low,
moderate, or high degrees of lymphoplasmocytic infiltration
(data not published). Since bystander lymphocytes of the
stroma were EBNA-1–, it could be assumed that the cellu-
lar source of the PCR EBV signal was the epithelial tumor
cells. This hypothesis is supported by the findings of Fina
and colleagues, who showed EBV genome localization in
specific tumor epithelial cell population of breast carci-
noma by laser capture microdissection combined with real-
time quantitative BamHIC PCR [5].
In view of the above data, the evidence regarding a possi-
ble association of EBV with breast carcinoma is controver-
sial and there are many facts to support arguments both
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